Crossmark

Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy

Crossref DOI link: https://doi.org/10.1186/s12879-023-08443-1

Published Online: 2023-07-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Qianqian

Ye, Jun

Zhang, Yafei

Zhang, Peixin

Xia, Guomei

Zhu, Jie

Wei, Shaofeng

Li, Xu

Zhang, Zhenhua
License Information

Text and Data Mining valid from 2023-07-10

Version of Record valid from 2023-07-10
More Information

Article History

Received: 21 February 2023

Accepted: 4 July 2023

First Online: 10 July 2023

Declarations

:

: The protocols and sample collection for the present study was reviewed and approved by the Anhui Medical University Ethics Committee Review Board (approval number: 2012624). Signed informed consent was provided by patients or surrogates. All methods were performed in accordance with the relevant guidelines and regulations (Declaration of Helsinki).

: Not applicable.

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below